自付费用是否影响成人类风湿关节炎患者的用药依从性?一项系统综述
该系统综述检索12个数据库至2016年4月,纳入6篇高质量原始研究,其中3篇以自付费用与用药依从性的关联为主要目的。尽管各研究人群与方法差异较大,自付费用与类风湿关节炎患者用药依从性呈反向关系;作者认为自付费用可导致不依从,建议全球卫生政策制定者确定合适的自付金额。
要点
- 纳入6篇高质量研究,其中3篇直接以自付费用与用药依从性的关联为主要目的。
- 各研究人群与方法差异较大,但自付费用与类风湿关节炎患者用药依从性呈反向关系。
- 作者认为自付费用可导致类风湿关节炎患者用药不依从。
核心结论
- 作者认为自付费用可导致类风湿关节炎患者用药不依从。
- 作者建议全球卫生政策制定者确定合适的自付金额,使这些费用不影响依从性,同时确保费用不会成为政府、服务提供者和保险公司的不可承受负担。
研究设计与样本
- 系统综述,检索12个数据库,纳入从建库至2016年4月发表的英文同行评议原始研究。
- 采用CASP清单评估纳入研究的质量。
- 共纳入6篇文章,均被评为高质量研究,其中3篇直接以自付费用与用药依从性的关联为主要目的。
主要发现
- 尽管各研究的人群和方法差异较大,自付费用与类风湿关节炎患者的用药依从性呈反向关系。
- 纳入的3篇研究直接以自付费用与用药依从性的关联为主要目的。
局限性
- 各研究的人群和方法差异较大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: For individuals with a chronic condition, long-term management of their medication can be difficult and as a result non-adherence is common among this cohort. In patients with rheumatoid arthritis (RA), the introduction of biologic agents was a revolutionary treatment but the high costs of this medication might limit their utilisation. OBJECTIVE: This systematic review aimed to determine whether out-of-pocket (OOP) costs affect adherence to RA medications in adults with a diagnosis of RA. METHODS: Twelve databases were searched to identify primary peer-reviewed articles, written in English from inception to April 2016 that referred to the relationship between adherence to RA medication and OOP costs. The CASP check list was used to assess the quality rating of the included studies. RESULTS: Six articles were identified in the review and all were considered as high quality studies. Among them, three directly considered the association between OOP costs and medication adherence as their main objective. Although the population and the methods of the studies varied widely, there was an inverse relationship between OOP costs and medication adherence in patients with RA. CONCLUSION: The findings of this review suggest that OOP costs can contribute to non-adherence to RA medication in patients with RA. Therefore, health policy makers globally should identify the appropriate OOP amount so these costs do not affect adherence whilst simultaneously ensuring that costs are not an intolerable burden for governments, providers and insurers.
引用
- Heidari P, Cross W, Crawford K, et al. Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review. Semin Arthritis Rheum. 2018. PMID: 29496225. doi:10.1016/j.semarthrit.2017.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。